Technical report series: cytokines

Biological products, rDNA

Title: Biological products prepared by recombinant DNA technology; Adopted 1990, TRS No 814, Annex 3

Interferons, human

Title: Requirements for Human Interferons prepared from Lymphoblastoid Cells; Adopted 1988, TRS No 786, Annex 3

Interferons, human

Title: Requirements for Human interferons made by recombinant DNA techniques; Adopted 1987, TRS No 771, Annex 7


  • WHO Working Group meeting on the development of guidelines on labelling influenza vaccines intended to be used for pregnant women, WHO HQ, Geneva, Switzerland, 24-25 September 2015
  • Expert Committee on biological Standardization, WHO HQ, Geneva, Switzerland, 12-16 October 2015
  • WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines, Chiang Mai, Thailand, 18-20 November 2015


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971